CClinicalTrials.gg
CompletedNCT03236337Updated Jul 13, 2018

Effectiveness of MOVI Interventions on Adiposity, Cognition and Subclinical Atherosclerosis: MOVI-daFit!

An interventional study of MOVI intervention in Physical Activity, Obesity and Children, sponsored by University of Castilla-La Mancha. Completed at 2 sites in Spain. Open to participants aged 8 Years to 11 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-07-13.

Sponsored by University of Castilla-La Mancha · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
570
Allocation
Randomized
Ages
8 Years to 11 Years
Sex
All
01

Study summary

Project which objective is to test the effectiveness of an extracurricular physical activity intervention based on high intensity interval training (MOVI-daFit!) on improving cardiorespiratory fitness (CRF), cardiometabolic risk, executive function, and academic performance.

Read the detailed description

In the last decade, this research group has tested the effectiveness of three interventions following this model. The first one (MOVI) was carried out in peripuberal age children (4th and 5th year of primary education, 8-11 years) and showed a moderate effect in reducing the adiposity of schoolchildren with higher BMI, an improvement of the lipid profile, without significantly improving the global cardiometabolic risk because it did not produce a reduction in insulinemia.

The second edition (MOVI-2), carried out at schoolchildren of the same age range, increased the duration and intensity of the sessions, and was focused on the development of muscular strength in order to improve insulinemia levels. The intervention showed proved effectiveness; in addition, the data from this intervention showed a modest improvement in girls' aerobic capacity, but not in boys.

The last edition (MOVI-KIDS) was aimed at children aged 4 to 7 years to test the hypotheses that vigorous physical activity at early ages could produce lifelong cardio-metabolic benefits. Data submitted for publication in this study show that, as in the case of the IDEFICS study in children of similar age, the intervention was not effective in improving fitness.

This new edition (MOVI-daFit!) has been designed as controlled cluster-randomized trial including 10 schools from Cuenca province, Spain. Five schools will be randomized to intervention group (IG), in which the intervention MOVI-daFit! will be conducted for children in fourth and fifth school grades (9-11 years old). The other five schools will be allocated to the control group (CG).

During an academic year the 4th and 5th schoolchildren allocated to IG will be carry out, in out of school hours, four times by week, one hour sessions of a standardized recreative, non competitive, physical activity intervention based on games adapted to high intensity interval training methodology (MOVI-daFit!). In the CG regular physical activity will continue.

At the end of the school year the researchers will determine main outcome variables: changes in VO2max, body fat by bioimpedance, reactive hyperemia index, academic achievement, executive function, and biochemical analytic procedures including lipid profile, insulin, HbA1, C ultrasensitive reactive protein and BDNF.

The hypotheses of this new edition will be that the MOVI-daFit! based on high intensity interval training (HITT) adapted for the 4th and 5th schoolchildren, will:

  1. Increase the aerobic capacity (VO2max).
  2. Reduce the percentage of body fat in the GI versus the GC by 6%.
  3. Improve executive function and academic performance.
  4. Improve subclinical markers of atherosclerosis (endothelial function and carotid intima-media thickness).
02

Conditions studied

  • Physical Activity
  • Obesity
  • Children
  • Cardiovascular
  • Cardiorespiratory Fitness

Keywords

  • Physical activity
  • Obesity
  • Children
  • Cognitive function
  • Academic achievement
  • Cardiorespiratory fitness
  • Adiposity
  • Cardiovascular fitness
  • Atherosclerosis
  • Aerobic capacity
03

In context

Atherosclerosis

1,567 studies on the registry are indexed under Atherosclerosis; 264 are open to participants now.

This study's enrollment of 570 is above the median of 106 across 882 interventional studies indexed under Atherosclerosis.

Browse Atherosclerosis studies →

Lead sponsor

University of Castilla-La Mancha is the lead sponsor of 104 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Schools must have at least one full classrooms for both the 4th and 5th grade of primary school.
  • The approval of boards of governors will be necessary.
  • Children's parents or legal representatives will sign an informed consent to participate.
  • Parents will be invited to collaborate by filling in questionnaires with regard to family leisure habits, sleeping, eating and getting around town.

Exclusion criteria

Exclusion criteria:

  • Severe Spanish language learning difficulties.
  • Serious physical or mental disorders identified by parents or teachers that would impede participation in the programme's activities.
  • Children diagnoses of chronic disorders, such as heart disease, diabetes or asthma, which in the opinion of their paediatricians would prevent their participation in the programme's activities (MOVI-daFit!).
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
570 participants (actual)

Study arms

  • No intervention
    Control

    No intervention

  • Experimental
    MOVI intervention

    - MOVI-da Fit! is a high intensity interval training intervention that consists on: a) 4 h/week of a standardized recreative, non-competitive physical activity extracurricular program; and b) informative sessions to parents and teachers about how schoolchildren can became more active. It is aimed to enhance physical fitness, motor skills, physical activity time and active behaviours among 9-to-11 years old children.

    Behavioral: MOVI intervention

Interventions

  • BehavioralMOVI intervention

    MOVI-da Fit! is a multidimensional intervention that consists on: a) 4h/week of a standardized recreative, non-competitive physical activity extracurricular program; and b) informative sessions to parents and teachers about how schoolchildren can became more active. It is aimed to enhance physical fitness, motor skills, physical activity time and active behaviours among 9-to-11 years old children.

    Also known as: MOVI-da Fit!

06

What researchers measure

Primary outcomes

  1. VO2 max

    It will be assessed by using 20-m shuttle run test, which is validated to measure maximal aerobic capacity in children from 5 years.

    Time frame: One year

Secondary outcomes

  1. BDNF blood determination

    Biochemical determinations will be performed in order to determine Brain-derived neurotrophic factor. It is a protein that, in humans, is encoded by the BDNF gene. BDNF acts on certain neurons of the central nervous system and the peripheral nervous system, helping to support the survival of existing neurons, and encourage the growth and differentiation of new neurons and synapses. In the brain, it is active in the hippocampus, cortex, and basal forebrain-areas vital to learning, memory, and higher thinking.

    Time frame: One year

  2. Health-related quality of life

    By using the KIDSCREEN-27 for children from 8 years.

    Time frame: One year

  3. Sleep behaviors and sleep problems by questionnaire

    By using the Spanish version of the Children's Sleep Habits Questionnaire (CSHQ) completed by parents. Four questions will be added in order to ask about bedtime, waking up, getting up, and total number of hours of sleep.

    Time frame: One year

  4. Sleep quality by accelerometry

    The latency, quantity, duration of sleep and the number of awakenings will also be measured by accelerometry in a subsample of 242 school children. Actigraphy (ACT) is a non-invasive method used to study sleep-wake patterns and circadian rhythms by assessing movement. The GENEActive (ActivInsights) monitor will be used, a wristwatch device that monitors activity levels for extended continuous periods.

    Time frame: One year

  5. Motor skills

    By using the Movement Assessment Battery for Children 2 (M-ABC 2)

    Time frame: One year

  6. Physical activity

    In a sub-sample of 242 randomly selected school children will be measured objectively by GENEActive (ActivInsights) accelerometers during seven consecutive days (including nights), with a fixed frequency of 85.7Hz to collect raw acceleration data measured in g for each axis of motion (x, y, z).

    Time frame: One year

  7. Body fat%

    Body fat percentage measured by Bioimpedance analysis

    Time frame: One year

  8. Academic achievement

    Children´s mean scores on mathematics and language will be considered

    Time frame: One year

  9. Arterial Stiffness

    Carotid intima-media thickness measurement through Sonosite Micromax ultrasound (Sonosite Inc., Bothell, Washington, USA).

    Time frame: One year

  10. Pulse wave velocity

    Pulse wave velocity measurement through SphymgoCor System (AtCor Medical Pty Ltd Head Office, West Ryde, Australia)

    Time frame: One year

  11. Subclinical atherosclerosis

    Reactive Hyperemia index measurement through ENDO- PAT (Moerland et al. Int J Vasc Med, 2012; 17; 682-86)

    Time frame: One year

  12. Executive function

    Executive function will be measured by standardized tests using the NIH toolbox

    Time frame: One year

  13. Glucose profile

    Glucose (mg/dl) level will be determined by using a system Cobas 8000 of Roche Diagnostics

    Time frame: One year

  14. Lipid profile

    Apolipoproteins (mg/dl) level will be determined by using a system Cobas 8000 of Roche Diagnostics.

    Time frame: One year

  15. Insulin profile

    Insulin (µU/L) level will be determined by using the Architect platform of Abbott ®

    Time frame: One year

  16. Ultrasensitive protein profile

    C-reactive protein ultrasensitive (mg/l) level will be determined by using a system Cobas 8000 of Roche Diagnostics

    Time frame: One year

07

Study locations

2 sites
  • Health and Social Research Centre, University of Castilla-La Mancha
    Cuenca, 16071, Spain
  • Mairena Sánchez-López
    Cuenca, 16071, Spain
08

References and documents

Publications

  • Pozuelo-Carrascosa DP, Martinez-Vizcaino V, Torres-Costoso A, Martinez MS, Rodriguez-Gutierrez E, Garrido-Miguel M. "Fat but Fit" Paradox and Cardiometabolic Risk in Children: The Role of Physical Activity. Child Obes. 2023 Jun;19(4):282-291. doi: 10.1089/chi.2022.0073. Epub 2022 Jul 26. PubMed 35881859 ↗
  • Martinez-Vizcaino V, Garrido-Miguel M, Redondo-Tebar A, Notario-Pacheco B, Rodriguez-Martin B, Sanchez-Lopez M. The "Fat but Fit" Paradigm from a Children's Health-Related Quality of Life Perspective. Child Obes. 2021 Oct;17(7):449-456. doi: 10.1089/chi.2021.0041. Epub 2021 May 18. PubMed 34009010 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 13, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03236337
Lead sponsor
University of Castilla-La Mancha
Collaborators
Carlos III Health Institute
Responsible party
Sponsor
First posted
Aug 1, 2017
Start date
Sep 19, 2017
Primary completion
Jun 30, 2018
Completion
Jun 30, 2018
Last update
Jul 13, 2018

Study contacts

Vicente Martínez-Vizcaíno, PhD, MD
principal investigator · Social and Health Care Research Center, University of Castilla-La Mancha

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion